Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like Siemens Summons Three Banks for IPO of Healthineers Unit October 25, 2017 Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran December 14, 2017 Delcath Systems Announces Adjournment Of Annual Meeting Meeting Scheduled To Reconvene On June 16 June 5, 2017
Delcath Systems Announces Adjournment Of Annual Meeting Meeting Scheduled To Reconvene On June 16 June 5, 2017
